Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$3.6 million.

  • Volitionrx's Free Cash Flow rose 3427.53% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.8 million, marking a year-over-year decrease of 3624.48%. This contributed to the annual value of -$26.2 million for FY2024, which is 3678.55% down from last year.
  • Per Volitionrx's latest filing, its Free Cash Flow stood at -$3.6 million for Q3 2025, which was up 3427.53% from -$6.3 million recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Free Cash Flow peaked at $6.1 million during Q4 2023, and registered a low of -$8.9 million during Q1 2023.
  • In the last 5 years, Volitionrx's Free Cash Flow had a median value of -$6.3 million in 2025 and averaged -$5.2 million.
  • Within the past 5 years, the most significant YoY rise in Volitionrx's Free Cash Flow was 19618.6% (2023), while the steepest drop was 35662.61% (2023).
  • Quarter analysis of 5 years shows Volitionrx's Free Cash Flow stood at -$4.5 million in 2021, then crashed by 40.65% to -$6.4 million in 2022, then soared by 196.19% to $6.1 million in 2023, then tumbled by 189.97% to -$5.5 million in 2024, then surged by 34.26% to -$3.6 million in 2025.
  • Its last three reported values are -$3.6 million in Q3 2025, -$6.3 million for Q2 2025, and -$4.3 million during Q1 2025.